This bill enacts new provisions in Louisiana law regarding prior authorizations for certain medications, specifically focusing on generic medications. It introduces definitions for key terms such as "board-certified physician," "commercial insurer," "generic medication," and "prior authorization." The bill stipulates that a commercial insurer cannot require prior authorization for the dispensing or reimbursement of a generic medication that is not an opioid, provided that the prescription is issued by a qualified board-certified physician or authorized provider and the medication's wholesale acquisition cost does not exceed $250.

The provisions of this Act will apply to any new health insurance policies, contracts, or coverage plans issued on or after January 1, 2027. Existing policies will need to conform to these new requirements by their renewal date, but no later than January 1, 2028. This legislation aims to streamline access to necessary medications while ensuring that qualified healthcare providers can prescribe them without unnecessary administrative barriers.